3,138
Views
2
CrossRef citations to date
0
Altmetric
Depression

How significant is the assessment of the DSM-5 'anxious distress' specifier in patients with major depressive disorder without comorbid anxiety disorders in the continuation/maintenance phase?

ORCID Icon, , , , &
Pages 385-392 | Received 03 May 2020, Accepted 18 Mar 2021, Published online: 11 Apr 2021

References

  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington (VA): American Psychiatric Publication. ISBN-13: 978-0890425558.
  • Beutel ME, Klein EM, Brähler E, Reiner I, Jünger C, Michal M, Wiltink J, Wild PS, Münzel T, Lackner KJ, et al. 2017. Loneliness in the general population: prevalence, determinants and relations to mental health. BMC Psychiatry. 17(1):97.
  • Coryell W, Endicott J, Andreasen NC, Keller MB, Clayton PJ, Hirschfeld RM, Scheftner WA, Winokur G. 1988. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry. 145(3):293–300.
  • Erfurth A, Gerlach AL, Hellweg I, Boenigk I, Michael N, Akiskal HS. 2005. Studies on a German (Münster) version of the temperament auto-questionnaire TEMPS-A: construction and validation of the briefTEMPS-M. J Affect Disord. 85(1–2):53–69.
  • Fava M, Rush AJ, Alpert JE, Carmin CN, Balasubramani GK, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K. 2006. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry. 51(13):823–835.
  • Fichter MM, Quadflieg N, Fischer UC, Kohlboeck G. 2009. Twenty-five-year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study. Acta Psychiatr Scand. 122(1):75–85.
  • Gaspersz R, Lamers F, Kent JM, Beekman AT, Smit JH, van Hemert AM, Schoevers RA, Penninx BW. 2017a. Longitudinal predictive validity of the DSM-5 anxious distress specifier for clinical outcomes in a large cohort of patients with major depressive disorder. J Clin Psychiatry. 78(02):207–213.
  • Gaspersz R, Lamers F, Kent JM, Beekman ATF, Smit JH, van Hemert AM, Schoevers RA, Penninx BWJH. 2017b. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment. J Psychiatr Res. 84:41–48.
  • Ghaemi SN. 2013. Bipolar spectrum: a review of the concept and a vision for the future. Psychiatry Investig. 10(3):218–224.
  • Goes FS, McCusker MG, Bienvenu OJ, Mackinnon DF, Mondimore FM, Schweizer B, Depaulo JR, Potash JB, National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium. 2012. Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychol Med. 42(7):1449–1459.
  • Husain MM, Rush AJ, Sackeim HA, Wisniewski SR, McClintock SM, Craven N, Holiner J, Mitchell JR, Balasubramani GK, Hauger R. 2005. Age-related characteristics of depression: a preliminary STAR*D report. Am J Geriatr Psychiatry. 13(10):852–860.
  • Ionescu DF, Niciu MJ, Richards EM, Zarate CA Jr. 2014. Pharmacologic treatment of dimensional anxious depression: a review. Prim Care Companion CNS Disord. 16:13r01621.
  • Iwanami T, Maeshima H, Baba H, Satomura E, Namekawa Y, Shimano T, Suzuki T, Arai H. 2015. Psychomotor agitation in major depressive disorder is a predictive factor of mood-switching. J Affect Disord. 170:185–189.
  • Liao A, Walker R, Carmody TJ, Cooper C, Shaw MA, Grannemann BD, Adams P, Bruder GE, McInnis MG, Webb CA, et al. 2019. Anxiety and anhedonia in depression: associations with neuroticism and cognitive control. J Affect Disord. 245:1070–1078.
  • Lin CH, Wang FC, Lin SC, Chen CC, Huang CJ. 2014. A comparison of inpatients with anxious depression to those with nonanxious depression. Psychiatry Res. 220(3):855–860.
  • Maneeton N, Suttajit S, Maneeton B, Likhitsathian S, Eurviyanukul K, Udomratn P, Chan ES, Si TM, Sulaiman AH, Chen CH, et al. 2017. Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder. Nord J Psychiatry. 71(7):503–508.
  • McIntyre RS, Weiller E, Zhang P, Weiss C. 2016a. Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: results from a post-hoc analysis of two randomised controlled trials. J Affect Disord. 201:116–123.
  • McIntyre RS, Woldeyohannes HO, Soczynska JK, Vinberg M, Cha DS, Lee Y, Gallaugher LA, Dale RS, Alsuwaidan MT, Mansur RB, et al. 2016b. The prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative Project. Ther Adv Chronic Dis. 7(3):153–159.
  • Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET. 2002. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry. 63(2):126–134.
  • Mendlowicz MV, Akiskal HS, Kelsoe JR, Rapaport MH, Jean-Louis G, Gillin JC. 2005. Temperament in the clinical differentiation of depressed bipolar and unipolar major depressive patients. J Affect Disord. 84(2–3):219–223.
  • Merino H, Senra C, Ferreiro F. 2016. Are worry and rumination specific pathways linking neuroticism and symptoms of anxiety and depression in patients with generalized anxiety disorder, major depressive disorder and mixed anxiety-depressive disorder? PLoS One. 11(5):e0156169.
  • Miyaoka H, Otsubo T, Yoshimura Y, Kamijima K, Miyaoka Y. 1999. Reliability and validity of the modified Japanese version of short-form Eysenck Personality Questionnaire. Showa Univ Med Sci. 11(1):33–36.
  • Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R, Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I. 2016. Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults. Neuropsychiatr Dis Treat. 12:2173–2179.
  • Otsubo T, Tanaka K, Koda R, Shinoda J, Sano N, Tanaka S, Aoyama H, Mimura M, Kamijima K. 2005. Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin Neurosci. 59(5):517–526.
  • Rane LJ, Fekadu A, Wooderson S, Poon L, Markopoulou K, Cleare AJ. 2010. Discrepancy between subjective and objective severity in treatment-resistant depression: prediction of treatment outcome. J Psychiatr Res. 44(15):1082–1087.
  • Rhebergen D, Batelaan NM, de Graaf R, Nolen WA, Spijker J, Beekman AT, Penninx BW. 2011. The 7-year course of depression and anxiety in the general population. Acta Psychiatr Scand. 123(4):297–306.
  • Seo HJ, Jung YE, Kim TS, Kim JB, Lee MS, Kim JM, Lim HW, Jun TY. 2011. Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression. J Nerv Ment Dis. 199(1):42–48.
  • Sheehan DV, Harnett-Sheehan K, Raj BA. 1996. The measurement of disability. Int Clin Psychopharmacol. 11:89–95.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59:22–33.
  • Shim IH, Woo YS, Bahk WM. 2016. Associations between immune activation and the current severity of the "with anxious distress" specifier in patients with depressive disorders. Gen Hosp Psychiatry. 42:27–31.
  • Sugawara H, Tsutsumi T, Inada K, Ishigooka J, Hashimoto M, Takebayashi M, Nishimura K. 2019. Association between anxious distress in a major depressive episode and bipolarity. Neuropsychiatr Dis Treat. 15:267–270.
  • Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, et al. 2004. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 34(1):73–82.
  • Tundo A, Musetti L, de Filippis R, Grande CD, Falaschi V, Proietti L, Dell'Osso L. 2019. Is there a relationship between depression with anxious distress DSM-5 specifier and bipolarity? A multicenter cohort study on patients with unipolar, bipolar I and II disorders. J Affect Disord. 245:819–826.
  • Zimmerman M, Chelminski I, Young D, Dalrymple K, Walsh E, Rosenstein L. 2014. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder. J Clin Psychiatry. 75(06):601–607.
  • Zimmerman M, Clark H, McGonigal P, Harris L, Holst CG, Martin J. 2017. Reliability and validity of the DSM-5 Anxious Distress Specifier Interview. Compr Psychiatry. 76:11–17.
  • Zimmerman M, Martin J, McGonigal P, Harris L, Kerr S, Balling C, Kiefer R, Stanton K, Dalrymple K. 2019. Validity of the DSM-5 anxious distress specifier for major depressive disorder. Depress Anxiety. 36(1):31–38.